- Home
- EDIT vs IHRT Comparison
EDIT vs IHRT Comparison
Compare EDIT & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- IHRT
- Stock Information
- Founded
- EDIT 2013
- IHRT 1974
- Country
- EDIT United States
- IHRT United States
- Employees
- EDIT N/A
- IHRT N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- IHRT Broadcasting
- Sector
- EDIT Health Care
- IHRT Consumer Discretionary
- Exchange
- EDIT Nasdaq
- IHRT Nasdaq
- Market Cap
- EDIT 263.7M
- IHRT 292.3M
- IPO Year
- EDIT 2016
- IHRT 2019
- Fundamental
- Price
- EDIT $2.28
- IHRT $1.65
- Analyst Decision
- EDIT Buy
- IHRT Buy
- Analyst Count
- EDIT 12
- IHRT 3
- Target Price
- EDIT $6.20
- IHRT $2.92
- AVG Volume (30 Days)
- EDIT 2.2M
- IHRT 385.6K
- Earning Date
- EDIT 08-19-2025
- IHRT 08-11-2025
- Dividend Yield
- EDIT N/A
- IHRT N/A
- EPS Growth
- EDIT N/A
- IHRT N/A
- EPS
- EDIT N/A
- IHRT N/A
- Revenue
- EDIT $35,837,000.00
- IHRT $3,862,595,000.00
- Revenue This Year
- EDIT N/A
- IHRT N/A
- Revenue Next Year
- EDIT N/A
- IHRT $5.89
- P/E Ratio
- EDIT N/A
- IHRT N/A
- Revenue Growth
- EDIT N/A
- IHRT 3.31
- 52 Week Low
- EDIT $0.91
- IHRT $0.95
- 52 Week High
- EDIT $4.90
- IHRT $2.84
- Technical
- Relative Strength Index (RSI)
- EDIT 43.28
- IHRT 34.18
- Support Level
- EDIT $2.37
- IHRT $1.54
- Resistance Level
- EDIT $2.67
- IHRT $1.87
- Average True Range (ATR)
- EDIT 0.23
- IHRT 0.10
- MACD
- EDIT -0.08
- IHRT -0.05
- Stochastic Oscillator
- EDIT 5.37
- IHRT 18.37
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.